Midgard Science

Labs / CDMO: development & manufacturing

Chongqing Sintaho Pharmaceutical Co., Ltd.

Chongqing, China · en.sintaho.com

GMP · GLP

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Chongqing Sintaho Pharmaceutical Co., Ltd. is an API enterprise founded in 2016 in Banan District, Chongqing, China. It provides R&D, production, registration, domestic and international marketing of APIs, with business focused on high-potency/cytotoxic APIs, peptides, and XDC compounds.

Their website has a general contact form; we send your quote request through it.

What they offer

  • API R&D

    Develops active pharmaceutical ingredients across its business segments.

  • API production

    Manufactures APIs through its GMP supporting systems and dedicated production lines.

  • API registration support

    Supports registration activities for APIs.

  • Domestic and international API marketing

    Markets APIs in China and overseas markets.

  • CDMO services

    Provides contract development and manufacturing services for global partners.

  • CMO services

    Provides contract manufacturing services for global partners.

  • High-potency API development and manufacturing

    Works on high-potency and cytotoxic API programs using dedicated production lines.

  • Peptide development and manufacturing

    Develops and manufactures peptide products, including GLP-1 APIs.

  • XDC compound development and manufacturing

    Develops and manufactures XDC compounds and related linker-payload combinations.

  • Structural modification

    Offers structural modification as part of its C(D)MO portfolio.

  • Regulatory filing support

    Supports DMF, CEP, and ASMF filings.

  • Process scaling

    Scales processes from gram to hundred-kilogram batches.

  • Commercial supply

    Provides commercial supply for API and related projects.

  • Full-life-cycle management

    Supports post-approval change management, CPV, and responses to pharmacopoeia method revisions.

What they work on

Modalities
Small molecule, ADC, Peptide
Assays and studies
HPLC purity, single-impurity control, impurity profiling, structural characterization, immunogenicity risk assessment, genotoxic impurity (GTI) control
Instruments and platforms
fully closed isolator systems
Scale and capacity
approximately 55,000 m² of GMP-compliant manufacturing space, 1,500 kg-per-annum peptide production line for GLP-1 APIs, commercial-scale manufacturing of high-potency compounds up to 50 kg
Type
CRDMO
Sites
Chongqing, China
Quality
GMP (long-time GMP compliance) · US FDA on-site inspection (passed in 2024 and 2025) · Australian TGA remote GMP inspection (passed in 2022) · France ANSM on-site inspection (passed in 2017)
Serves
China, United States, Canada, European Union, more than 30 countries
Founded
2016

Similar labs. Gannet BioChem, Porton, TRACER, Veranova

Found in a contract services directory. Listing built from en.sintaho.com. Work here? Claim this listing.

Chongqing Sintaho Pharmaceutical Co., Ltd. · Midgard Science